Robotic transanal total mesorectal excision: Is the future now?

Area of Science:

• Surgical Oncology
• Minimally Invasive Surgery
• Robotic Surgery

Background:

• Total mesorectal excision (TME) is the standard surgical treatment for rectal cancer.
• Minimally invasive TME, including transanal TME (TaTME), has emerged to address technical challenges in specific patient populations.
• Concerns regarding anastomotic leaks and local recurrences have been raised with conventional TaTME.

Purpose of the Study:

• To review the available literature on Robotic TaTME (R-TaTME).
• To analyze the potential benefits, harms, and future perspectives of R-TaTME.
• To assess the role of R-TaTME in rectal cancer treatment.

Main Methods:

• Literature review of available studies on R-TaTME.
• Analysis of short-term results and comparison with existing TME techniques.
• Focus on oncological and functional outcomes.

Main Results:

• R-TaTME combines perineal dissection benefits with robotic precision.
• Robotic technology offers improved dexterity and control for distal margins.
• Encouraging short-term outcomes have been reported for R-TaTME.

Conclusions:

• R-TaTME presents a novel approach for rectal cancer surgery.
• Further long-term studies are essential to validate its oncological and functional efficacy.
• The precise role of R-TaTME in rectal cancer management requires continued investigation.